U.K. Biobank has 500,000 peoples' genome sequences available

AdobeLONDON—Datafromhalfamillionpeople’swholegenomesequencesarenowavailabletoresearchersworldwide,as MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef




explore

author：hotspot    Page View：464
Franklin faces
Adobe

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

advertisement

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： J&J to emphasize cancer drugs, stop much of its vaccine research
Next article： As demand for Covid shots wanes, Moderna seeks its next success